Skip to main content
. 2019 Dec 11;9:1400. doi: 10.3389/fonc.2019.01400

Table 2.

IMDC risk group classification.

KARNOFSKY PS <80%
Hemoglobin <lower normal limit
Corrected serum calcium >10 mg/dL
Period from diagnosis to treatment <1 year
Neutrophil counts >upper normal limit
Platelet count >upper normal limit
Prognosis Score Median overall survival (months) Survival at 2 years (%)
Good 0 NR 75
Intermediate 1–2 27 mos. 53
Poor 3–6 8.8 mos. 7

IMDC, International Metastatic RCC Database Consortium.